FDA Reviewing Safety of RSV Drugs for Infants, No Incidents Reported

FDA Reviewing RSV Drugs for Infants, Though No Safety Issues Found

FDA reviewing safety of RSV drugs for infants, no incidents reported

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported.

FDA Opens Safety Review of Injectable RSV Drugs Approved for Babies and Toddlers

(MedPage Today) -- FDA officials opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, the respiratory virus that sends thousands of American children to the hospital each year. The long-acting drugs from...

FDA opens safety review into drugs given to babies and toddlers for RSV

FOOD and Drug Administration officials have opened an investigation into a common drug given to babies and toddlers. The drug is used to prevent...

FDA Plans to Review Already Approved RSV Immunizations

Reports are surfacing the federal agency is going to review products already reviewed and approved.